Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIM-SOF Trial: Simeprevir + Sofosbuvir vs Standard of Care in HCV GT1a Cirrhosis
NCT02168361Phase 4Completed
- Sponsor
- Center for the Study of Hepatitis C
- Start
- Dec 2013
- Primary completion
- Dec 2014
- Modality
- Reversible Covalent Inhibitors, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of simeprevir in hepatitis C (HCV), sponsored by Center for the Study of Hepatitis C. Started Dec 2013; status: completed.
02
Drugs
simeprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02168361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02168361.